Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 35

Sort by

Sort Order Select

Journal Articles

EHA-ESH Tutorials on Diagnostics in Hematological Malignancies: A Didactic Model for Training Programs in Hematology in Developing Countries

Gina Zini, MD, Barbara Bain, MD, Didì Jasmin, Robert Foa, MD

Blood (2008) 112 (11): 4710.

https://doi.org/10.1182/blood.V112.11.4710.4710

Published: 2008

Journal Articles

Bendamustine Versus Chlorambucil as First-Line Treatment in B Cell Chronic Lymphocytic Leukemia: An Updated Analysis from An International Phase III Study.

Wolfgang Ulrich Knauf, Toshko Lissitchkov, Ali Aldaoud, Anna Liberati, Javier Loscertales, Roul Herbrecht, Gunnar Juliusson, MD, Gerhard Postner, Liana Gercheva, Stefan Goranov, MD, Martin Becker, Klaus Hoeffken, Francoise Huguet, Robert Foa, MD, Karlheinz Merkle, Marco Montillo

Blood (2008) 112 (11): 2091.

https://doi.org/10.1182/blood.V112.11.2091.2091

Published: 2008

Journal Articles

The BCL-2 Antagonist ABT-737 Is Highly Effective on Primary Acute Lymphoblastic Leukemia Cells.

Maria Rosaria Ricciardi, PhD, Chiara Gregorj, PhD, Fabiana De Cave, MS, Paola Bergamo, Samantha Decandia, MS, Sara Santinelli, Antonella Vitale, MD, Maria Teresa Petrucci, MD, Michele Milella, MD, Robert Foa, MD, Agostino Tafuri, MD

Blood (2007) 110 (11): 155.

https://doi.org/10.1182/blood.V110.11.155.155

Published: 2007

Journal Articles

Functional Effects of the Bcl-2/Bcl-xL Inhibitor ABT-737 on Primary Cells from Smoldering Multiple Myeloma.

Maria Rosaria Ricciardi, PhD, Elisabetta Calabrese, MD, Fabiana De Cave, PhD, Sara Santinelli, Paola Bergamo, Samantha Decandia, PhD, Chiara Gregorj, PhD, Vincenzo Federico, MD, Michele Milella, MD, Robert Foa, MD, Agostino Tafuri, MD, Maria Teresa Petrucci, MD

Blood (2007) 110 (11): 4782.

https://doi.org/10.1182/blood.V110.11.4782.4782

Published: 2007

Journal Articles

JAK2 (V617F) Mutation Levels and Marrow Fibrosis in Patients Affected by Budd-Chiari Syndrome and Non-Cirrhotic Extra-Hepatic Portal Vein Obstruction.

Angela Rago, MD, Chiara Marzano, MD, Corrado Mammì, MD, Carmelo Laganà, MD, Angelo Fama, MD, Luisa Bizzoni, MD, Gabriella Tomei, MD, Stefania Trasarti, MD, Francesca Gioisa, MD, Massimo Breccia, MD, Ida Carmosino, MD, Roberto Latagliata, MD, Giuliana Alimena, MD, Robert Foa, MD, Oliviero Riggio, MD, Agostino Tafuri, MD

Blood (2007) 110 (11): 4652.

https://doi.org/10.1182/blood.V110.11.4652.4652

Published: 2007

Journal Articles

Protein Expression of p15 and p21 Plays an Unfavorable Prognostic Role in Adult Acute Lymphoblastic Leukemia (ALL) Patients Independently of Their Gene Promoter Methylation Status.

Blood (2007) 110 (11): 2802.

https://doi.org/10.1182/blood.V110.11.2802.2802

Published: 2007

Journal Articles

IgV H Germline and Mutated Chronic Lymphocytic Leukemia (CLL) Cases Exert a Diverse Responsiveness upon BCR Ligation.

Simona Tavolaro, BS, Roberta Maggio, BS, Nadia Peragine, BS, Monica Messina, BS, Franca Citarella, PhD, Simona Santangelo Miss, Marilisa Marinelli, BS, Maria R. Ricciardi, PhD, Maria S. De Propris, PhD, Ilaria Del Giudice, MD, PhD, Francesca R. Mauro, MD, Sabina Chiaretti, MD, PhD, Robert Foa, MD, Anna Guarini, PhD

Blood (2007) 110 (11): 1133.

https://doi.org/10.1182/blood.V110.11.1133.1133

Published: 2007

Journal Articles

T Regulatory Cells Obtained from Cord Blood Are Greatly Expandable and Exert Potent Suppressive Function.

Giovanni F. Torelli, MD, PhD, Roberta Maggio, BS, Nadia Peragine, BS, Barbarella Lucarelli, MD, Maria S. De Propris, PhD, Maria Screnci, MD, Simona Salvatori, BS, Anna P. Iori, MD, PhD, Filippo Milano, MD, Veronica Valle, MD, Emilia Iannella, MD, Anna Guarini, PhD, Robert Foa, MD

Blood (2007) 110 (11): 4862.

https://doi.org/10.1182/blood.V110.11.4862.4862

Published: 2007

Journal Articles

Bone Metabolism and Endocrine Function in Children with Chronic Myeloid Leukemia (CML) Treated with Imatinib during Puberty.

Fiorina Giona, MD, Stefania Mariani, MD, Annalisa De Vellis, MD, Maria Luisa Moleti, MD, Anna Maria Testi, MD, Mariella D’Angiò, MD, Bruna De Masi, MD, Robert Foa, MD, Lucio Gnessi, MD

Blood (2007) 110 (11): 2942.

https://doi.org/10.1182/blood.V110.11.2942.2942

Published: 2007

Journal Articles

Gene Expression Profile Reveals a Unique Pattern of Protein Kinases in Chronic Lymphocytic Leukemia (CLL): Potential Role of the Second Generation Protein Kinase Inhibitors.

Simona Tavolaro, BS, Sabina Chiaretti, MD, PhD, Monica Messina, BS, Nadia Peragine, BS, Roberta Maggio, BS, Ilaria Del Giudice, MD, PhD, Emanuela M. Ghia, PhD, Francesca R. Mauro, MD, Anna Guarini, PhD, Robert Foa, MD

Blood (2007) 110 (11): 3117.

https://doi.org/10.1182/blood.V110.11.3117.3117

Published: 2007

Journal Articles

An International Multi-Center Study To Define the Application of Microarray-Based Gene Expression Profiling in the Diagnosis and Sub-Classification of Leukemia (MILE Study): Analysis of Completed Stage I with 2030 Patients Achieved a 95.4% Accuracy.

Blood (2007) 110 (11): 3169.

https://doi.org/10.1182/blood.V110.11.3169.3169

Published: 2007

Journal Articles

Type of Relapse in 91 Newly Diagnosed MM Patients Treated with High Dose Chemotherapy Followed by Autologous Stem Cell Transplantation.

Maria Teresa Petrucci, MD, Giuseppe Avvisati, MD, PhD, Ombretta Annibali, MD, Saveria Capria, MD, Maria S. De Propris, PhD, Patrizia Del Bianco, PhD, Vincenzo Federico, Cristiano Gallucci, MD, Maria Gozzer, MD, Chiara Gregorj, PhD, Annalisa Natale, MD, Azzurra Romeo, MD, Giovanna Meloni, MD, Robert Foa, MD

Blood (2006) 108 (11): 5451.

https://doi.org/10.1182/blood.V108.11.5451.5451

Published: 2006

Journal Articles

Fludarabine, Ara-C, Novantrone and Dexamethasone Plus Campath-1H for the Treatment of Patients with Chronic Lymphocytic Leukemia (CLL) and Adverse Clinical and Biologic Prognostic Features.

Francesca R. Mauro, MD, Elena Giammartini, MD, Maria S. De Propris, BD, Giuseppe Gentile, MD, Mauro Nanni, BD, Emanuela M. Ghia, BD, Irene Della Starza, BD, Ilaria Del Giudice, MD, Simona Santangelo, BD, Marilisa Marinelli, BD, Fulvia Brugnoletti, MD, Clara Minotti, MD, Vera Capria, MD, Anna Guarini, BD, Robert Foa, MD

Blood (2006) 108 (11): 2830.

https://doi.org/10.1182/blood.V108.11.2830.2830

Published: 2006

Journal Articles

Gene Expression Profile of Protein Kinases Reveals a Distinctive Signature of Chronic Lymphocytic Leukemia (CLL) and Points to a Role of Second Generation Protein Kinase Inhibitors.

Simona Tavolaro, BS, Sabina Chiaretti, MD, PhD, Monica Messina, BS, Francesca R. Mauro, MD, Ilaria Del Giudice, MD PhD, Roberta Maggio, BS, Emanuela M. Ghia, BS, Marilisa Marinelli, BS, Simona Santangelo Miss, Anna Guarini, PhD, Robert Foa, MD

Blood (2006) 108 (11): 2794.

https://doi.org/10.1182/blood.V108.11.2794.2794

Published: 2006

Journal Articles

Molecular and Functional Effects of the Novel MEK Inhibitor PD0325901 in Preclinical Models of Human Leukemias.

Michele Milella, MD, Maria Rosaria Ricciardi, PhD, Chiara Gregorj, PhD, Fabiana De Cave, PhD, Steven L. Abrams, BS, Linda S. Steelman, MS, Sabina Chiaretti, PhD, Marina Konopleva, MD, PhD, Maria Teresa Petrucci, MD, Francesco Cognetti, MD, Robert Foa, MD, PhD, Michael Andreeff, MD, PhD, James McCubrey, PhD, Agostino Tafuri, MD

Blood (2006) 108 (11): 254.

https://doi.org/10.1182/blood.V108.11.254.254

Published: 2006

Journal Articles

Protein Expression and Methylation Status of the CKI p21, p15 and p16 in Adult Acute Lymphoblastic Leukemia (ALL) Patients: Prognostic Implications.

Chiara Gregorj, PhD, Fabiana De Cave, MS, Maria Teresa Petrucci, MD, Maria R. Ricciardi, PhD, Maria C. Scerpa, MS, Sara Santinelli, Vincenzo Liso, MD, Rosario Giustolisi, MD, Andrea Camera, MD, Eugenio Gallo, MD, Felicetto Ferrara, MD, Francesco Nobile, MD, Nicola Cascavilla, MD, Francesco Fabbiano, MD, Giuseppe Leone, MD, Omar Perbellini, MD, Patrizio Mazza, MD, Luciana Annino, MD, Piero Galieni, MD, Eustachio Miraglia, MD, Massimo Martelli, MD, Giuseppe Torelli, MD, Nicola Cantore, MD, Antonio Peta, MD, Alfonso M. D’Arco, MD, Alessandra Tedeschi, MD, Giuseppe Fioritoni, MD, Antonio Cuneo, MD, Maura Brugiatelli, MD, Gianluca Gaidano, MD, PhD, Giuseppe Visani, MD, Ignazio Majolino, MD, Rosa Nieddu, MD, Mario Boccadoro, MD, Ernesto Capussela, MD, Antonella Vitale, MD, Giovanna Meloni, MD, Paola Fazzi, MD, PhD, Marco Vignetti, MD, Robert Foa, MD, Agostino Tafuri, MD

Blood (2006) 108 (11): 1843.

https://doi.org/10.1182/blood.V108.11.1843.1843

Published: 2006

Journal Articles

Protein Kinase Gene Expression Profile in Adult Acute Lymphocytic Leukemia (ALL): Identification of Novel Therapeutic Targets.

Monica Messina, BS, Sabina Chiaretti, MD, PhD, Simona Tavolaro, BS, Irene Della Starza Miss, Antonella Vitale, MD, Cristina Ariola, BS, Alina Negulici Miss, Loredana Elia, PhD, Anna Guarini, PhD, Robert Foa, MD

Blood (2006) 108 (11): 1824.

https://doi.org/10.1182/blood.V108.11.1824.1824

Published: 2006

Journal Articles

Rituximab Combined with M/VACOP-B and Radiotherapy in Primary Mediastinal Large B-Cell Lymphoma (PMLBCL): A Prospective Italian Phase II IIL Study.

Maurizio Martelli, MD, Vittorio Stefoni, MD, Giuseppina Cabras, MD, Sergio Cortellazzo, MD, Ercole Brusamolino, MD, Alessandro Levis, MD, Barbara Botto, MD, Antonio De Vivo, MD, Fiammetta Natalino, MD, Finolezzi Erica, MD, Robert Foa, MD, Pier Luigi Zinzani, MD

Blood (2006) 108 (11): 4697.

https://doi.org/10.1182/blood.V108.11.4697.4697

Published: 2006

Journal Articles

Histopathologic and Molecular Features of Persistent Polyclonal B-Cell Lymphocytosis Challenging the Benign Nature of the Disorder.

Ilaria Del Giudice, MD, PhD, Stefano A. Pileri, MD, Maura Rossi, BTD, Elena Sabattini, MD, Cristina Campidelli, MD, Irene Della Starza Miss, Stefania M. De Propris, PhD, Francesca Mancini, PhD, Francesca R. Mauro, MD, Agostino Tafuri, MD, Luisa Bizzoni, MD, Angela Rago, MD, Angela Amendola, MD, Anna Guarini, PhD, Robert Foa, MD

Blood (2006) 108 (11): 4612.

https://doi.org/10.1182/blood.V108.11.4612.4612

Published: 2006

Journal Articles

Rituximab in Refractory Idiopathic Thrombocytopenic Purpura (ITP).

Cristina Santoro, MD, Francesca Biondo, MD, Gioia De Angelis, MD, Mariastefania De Propris, BD, Annalisa De Vellis, MD, Anna Guarini, BD, Luigi Malandruccolo, MD, Angela Rago, MD, Robert Foa, MD, Mariagabriella Mazzucconi, MD

Blood (2006) 108 (11): 3979.

https://doi.org/10.1182/blood.V108.11.3979.3979

Published: 2006

NARROW

EHA-ESH Tutorials on Diagnostics in Hematological Malignancies: A Didactic Model for Training Programs in Hematology in Developing Countries

Bendamustine Versus Chlorambucil as First-Line Treatment in B Cell Chronic Lymphocytic Leukemia: An Updated Analysis from An International Phase III Study.

The BCL-2 Antagonist ABT-737 Is Highly Effective on Primary Acute Lymphoblastic Leukemia Cells.

Functional Effects of the Bcl-2/Bcl-xL Inhibitor ABT-737 on Primary Cells from Smoldering Multiple Myeloma.

JAK2 (V617F) Mutation Levels and Marrow Fibrosis in Patients Affected by Budd-Chiari Syndrome and Non-Cirrhotic Extra-Hepatic Portal Vein Obstruction.

Protein Expression of p15 and p21 Plays an Unfavorable Prognostic Role in Adult Acute Lymphoblastic Leukemia (ALL) Patients Independently of Their Gene Promoter Methylation Status.

IgV H Germline and Mutated Chronic Lymphocytic Leukemia (CLL) Cases Exert a Diverse Responsiveness upon BCR Ligation.

T Regulatory Cells Obtained from Cord Blood Are Greatly Expandable and Exert Potent Suppressive Function.

Bone Metabolism and Endocrine Function in Children with Chronic Myeloid Leukemia (CML) Treated with Imatinib during Puberty.

Gene Expression Profile Reveals a Unique Pattern of Protein Kinases in Chronic Lymphocytic Leukemia (CLL): Potential Role of the Second Generation Protein Kinase Inhibitors.

An International Multi-Center Study To Define the Application of Microarray-Based Gene Expression Profiling in the Diagnosis and Sub-Classification of Leukemia (MILE Study): Analysis of Completed Stage I with 2030 Patients Achieved a 95.4% Accuracy.

Type of Relapse in 91 Newly Diagnosed MM Patients Treated with High Dose Chemotherapy Followed by Autologous Stem Cell Transplantation.

Fludarabine, Ara-C, Novantrone and Dexamethasone Plus Campath-1H for the Treatment of Patients with Chronic Lymphocytic Leukemia (CLL) and Adverse Clinical and Biologic Prognostic Features.

Gene Expression Profile of Protein Kinases Reveals a Distinctive Signature of Chronic Lymphocytic Leukemia (CLL) and Points to a Role of Second Generation Protein Kinase Inhibitors.

Molecular and Functional Effects of the Novel MEK Inhibitor PD0325901 in Preclinical Models of Human Leukemias.

Protein Expression and Methylation Status of the CKI p21, p15 and p16 in Adult Acute Lymphoblastic Leukemia (ALL) Patients: Prognostic Implications.

Protein Kinase Gene Expression Profile in Adult Acute Lymphocytic Leukemia (ALL): Identification of Novel Therapeutic Targets.

Rituximab Combined with M/VACOP-B and Radiotherapy in Primary Mediastinal Large B-Cell Lymphoma (PMLBCL): A Prospective Italian Phase II IIL Study.

Histopathologic and Molecular Features of Persistent Polyclonal B-Cell Lymphocytosis Challenging the Benign Nature of the Disorder.

Rituximab in Refractory Idiopathic Thrombocytopenic Purpura (ITP).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only